Navigation Links
MRI with nanoparticles highly sensitive in detecting prostate cancer metastases

High-resolution MRI with magnetic nanoparticles is highly sensitive in detecting clinically occult lymph-node metastases in prostate cancer, according to a new report. In fact, routine use of this modality preoperatively could obviate many unneeded surgeries.//
The nanoparticles, which are given intravenously 24 hours before scanning, work by binding to lymphatic cells. The particles only bind to normal cells, so it is the areas that do not "light up" on MRI that are suspicious for malignancy.

MRI with magnetic nanoparticles "is very likely going to change the way cancers can be staged," say senior doctors. "In the study 25% of patients could have avoided surgery if scanning with nanoparticles had been done preoperatively." Currently, there is no way of knowing before surgery which patients will have microscopic tumor spread to the lymph nodes.

The findings, which are published in the June 19th issue of The New England Journal of Medicine, are based on a study of 80 men with prostate cancer who underwent lymph-node resection or biopsy. Prior to surgery, MRI was performed in all patients before and after infusion of nanoparticles. Of the 334 nodes removed, 63 had histologically proven metastases. With standard imaging criteria for malignancy, 45 of these nodes would have been falsely considered disease free.

MRI with nanoparticles correctly identified all of the patients with nodal disease. In addition, on node-by-node analysis, the sensitivity of this modality, at 90.5%, was significantly higher than that of conventional MRI, at 35.4% (p < 0.001). The nanoparticles appear to be very safe and none of the patients experienced any side effects so far.

The team has also tested the agent's ability to detect metastases from lung and breast cancer and it appears to work equally well. "That's the beauty of targeting normal cells rather than focusing on the malignant cells which always mutate ."

The nanoparticl es, which are being developed by Massachusetts-based Advanced Magnetics Inc. under the name Combidex, are in the final stages of approval by the US Food and Drug Administration.
'"/>




Related medicine news :

1. Threat posed by highly resistant strains of TB
2. Female Circumcision highly Prevalent in Mali
3. Sensitive to bright light? You may have sensitive teeth also
4. Some more sensitive to pain
5. Adult stem cells are sensitive to responses from the environment
6. HIV Positive Individuals Say Media Is Insensitive
7. Vitamin B12 can help in detecting cancers
8. New device for detecting artery blockages
9. Associated scan for detecting ovarian cancer spread
10. Tumour marker for detecting early Recurrence of Thyroid cancer may be soon available
11. Measuring disseminated cancer cells in bone marrow - valuable tool for detecting early breast cancer metastasis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/21/2017)... ... July 21, 2017 , ... The ... consultations to communities in the greater Denver region, is announcing a charity drive ... a very rare kind of epilepsy. , Until a few months ago, Dominik ...
(Date:7/21/2017)... ... July 21, 2017 , ... The Karen ... services to communities in the greater Birmingham area, is joining the Chris Hammond ... young people in the region. , The Chris Hammond Youth Foundation maintains athletic ...
(Date:7/21/2017)... PHILADELPHIA (PRWEB) , ... July 21, 2017 , ... ... ARTZ Philadelphia and Theater of Witness , was awarded a $300,000 ... growing humanities program which fosters empathy, comfort with ambiguity and the recognition of ...
(Date:7/21/2017)... ... July 21, 2017 , ... The Margarian Law Firm has filed a ... its ginger ale for allegedly containing no ginger. Dr. Pepper produces the “Canada Dry” ... plaintiff Gegham Margaryan alleges Canada Dry Ginger Ale claims on its bottle that it ...
(Date:7/21/2017)... , ... July 21, 2017 , ... ... medical students improve their chances of acceptance to a residency in a United ... have earned degrees outside the U.S. , According to data released by the ...
Breaking Medicine News(10 mins):
(Date:7/13/2017)... Md. , July 13, 2017  New York City-based ... of pharmaceutical markets should be aware of.  From new products ... trends are detailed in a recently completed study, Potential ... 1.  Age-Driven Growth ... we have been aware of the impact the growing population ...
(Date:7/11/2017)...  Bayer has awarded grants totaling more than $2 million ... prestigious Bayer Hemophilia Awards Program (BHAP). Four U.S. clinicians and ... and Uniformed Services University of the Health Sciences in ... recipients were announced last night during a reception at the ... Berlin, Germany . ...
(Date:7/11/2017)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ... the development of oral drug delivery systems, announced today ... agreed to schedule an End-of-Phase II meeting with Oramed ... oral insulin capsule ORMD-0801 in the treatment of type ... secondary endpoints by indicating a statistically significant lowering of ...
Breaking Medicine Technology: